Yves Blickenstorfer

BRCCH Consortium Member
ETH Zurich

Yves Blickenstorfer is a fourth year PhD student at ETH Zurich in the field of Biosensing. Prior to his PhD he has studied material’s science at ETH. In the past four years he has worked on developing and optimizing the hardware and software for different novel biosensing technologies and model their quantitative response. He is currently focusing on sensitive electrochemical detection of gold nanoparticles in order to improve rapid diagnostic testing. He has been part of the founding process of the Roche spin-off Lino Biotech and will be CTO of the newly founded ETH start-up Hemetron.

Research Consortia:


The latest updates from BRCCH